MedTrace Logo

Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

NCT00102674 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-08-16

No results posted yet for this study

Summary

The purposes of this study are to:

* Evaluate the tolerability of two cangrelor regimens.
* Compare the PD of cangrelor regimens with oral clopidogrel.

Conditions

  • Healthy

Interventions

DRUG

cangrelor

Sponsors & Collaborators

  • The Medicines Company

    lead INDUSTRY

Principal Investigators

  • Steven Steinhubl, MD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102674 on ClinicalTrials.gov